Home
Conditions
Lymphoma, T-Cell, Peripheral

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

239 public trials 60 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Recruiting

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

NCT07414758

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

NCT07389616

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Evaluate the Safety and Clinical Activity of HH2853

NCT04390737

Conditions: Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

NEXT Oncology San Antonio, Texas, United States

View all 25 locations

View Trial Details

Recruiting

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT06909877

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sichuan Cancer Hospital Chengdu, China

View Trial Details

Recruiting

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

NCT07353840

Conditions: Disease Attributes, Disease Progression, Hemic and Lymphatic Diseases, +14 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

NCT06776952

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

NCT07093710

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

NCT07253129

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Amping up With PemJAK

NCT07283822

Conditions: Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

Linperlisib Combined With Chidamide in Patients With PTCL

NCT06421948

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China

Liling Zhang Wuhan, Hubei, China

Yajun Li Changsha, Hunan, China

Ming Jiang Chengdu, Sichuan, China

View Trial Details

Lymphoma, T-Cell, Peripheral

Lymphoma, T-Cell, Peripheral trial results

Related conditions